FTNT vs ZYME · P/E 56, rev $6.80B vs rev $76.3M
Fortinet Inc (FTNT) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Fortinet Inc (FTNT) is a software - infrastructure company listed on NASDAQ.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported FTNT revenue for 2025-12-31 was $6.80B. Net income was $1.85B. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. FTNT currently screens at market cap $105.60B and trailing P/E 56.1.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
FTNT currently screens at market cap $105.60B and trailing P/E 56.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the FTNT and ZYME stock pages for the full models.
Not investment advice.